Navigation Links
Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers
Date:1/7/2009

SOUTH SAN FRANCISCO, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on innovative oncology therapies, today announced that the Company will present data from two ongoing Phase 2 clinical trials of picoplatin at two upcoming American Society of Clinical Oncology (ASCO) Symposia.

In January, the Company will present updated data from its Phase 2 trial of picoplatin in patients with metastatic colorectal cancer at ASCO's 2009 Gastrointestinal (GI) Cancers Symposium in San Francisco. In February, updated data from the ongoing Phase 2 trial of picoplatin in patients with metastatic hormone refractory (or castration resistant) prostate cancer will be presented at ASCO's Genitourinary (GU) Cancers Symposium in Orlando, Fla.

    Presentation details are as follows:
    --  The ASCO 2009 GI Cancers Symposium, San Francisco
        --  Randomized Phase 2 study of picoplatin in combination with
            5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparing
            alternative to mFOLFOX-6 as first-line therapy for colorectal
            cancer (CRC)
        --  R. H. Earhart, S. V. Cheporov, O. A. Gladkov, M. Y. Biakhov, G. S.
            Baker, H. B. Breitz
        --  Saturday, January 17, 12:30-1:30

    --  The ASCO 2009 GU Cancers Symposium, Orlando, Fla.
        --  Results of a Phase 2 study of picoplatin with docetaxel and
            prednisone in first-line treatment of metastatic hormone
            refractory prostate cancer (HRPC)
        --  R. Earhart, L. Roman, N. Lopatkin, P. Karlov,  H. Breitz, David
            Karlin, R. De Jager
        --  Friday, February 27, 11:45-1:15

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on th
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
2. Poniard Pharmaceuticals to Host Third Quarter 2008 Financial Results Conference Call on October 30
3. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
4. Poniard Announces Positive Incremental Efficacy and Safety Data From Ongoing Phase 2 Picoplatin Trial in Hormone-Refractory Prostate Cancer
5. Poniard Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
6. Poniard Pharmaceuticals Announces Upcoming Conference Participation
7. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
10. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
11. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the device," Nobel laureate Herbert Kroemer famously observed, ... at the junctures where layers of different materials ... interfaces between layers of metal oxides are becoming ... as spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing ...
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal ... been selected by Buffalo BioBlower Technologies LLC ("B3") as ... SBIR Phase 2 award from the Army Corps of ... system that kills all biological contaminants and destroys VOCs ...
(Date:1/15/2014)... JOSE, California , January 15, 2014 ... cancer, today announced the appointment of Thomas C Reynolds MD, ... 20 years, development experience gained in the biotechnology industry, most ... "I am delighted to welcome Tom at this transformative time ...
(Date:1/15/2014)... , January 15, 2014 A study ... races on the Formula 1 track could help to tackle ... Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... healthcare provider Simplyhealth. Telemetry technology, which is inspired ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... ... ... -- MODA Technology Partners will offer a live, interactive Webinar on the benefits and value ... 9:00 AM MT). The presentation will feature Marvin Thompson, Manager, Quality Operations at Talecris, and ...
... U.S. Department of Energy,s Argonne National Laboratory will ... in Electrochemical Energy Storage Beyond Lithium Ion: Computational ... electronics and renewable energy applications. Registration ... next generation of high-performance battery technologies is likely ...
... ... MM-111 breast cancer study in combination with trastuzumab. , ... Cambridge, MA (PRWEB) April 17, 2010 -- Merrimack ... the two lead candidates in the company’s pipeline of five novel cancer antibodies, at ...
Cached Biology Technology:Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 2Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 3Merrimack to Present Pre-Clinical Data on MM-121 and MM-111 at the 101st Annual Meeting of American Association for Cancer Research (AACR) 2Merrimack to Present Pre-Clinical Data on MM-121 and MM-111 at the 101st Annual Meeting of American Association for Cancer Research (AACR) 3
(Date:7/9/2014)... Calif. Sexual selection refers to species, selection for ... special type of natural selection enhances opportunities to mate, ... , Biologists at the University of California, Riverside have ... formation of a placenta are linked. Describing the ... in the family Poeciliidae, the researchers found that species ...
(Date:7/9/2014)... nature,s ability to split the water molecule during ... artificial photosynthesis for clean, green and renewable energy ... scientists led by researchers with the Lawrence Berkeley ... Accelerator Laboratory. , Working at SLAC,s Linac ... x-ray laser, the researchers were able to take ...
(Date:7/9/2014)... studying critically ill children with traumatic injuries have ... are likely to develop a hospital-acquired infection. The ... and published online in June in the journal ... efforts that could lead to the clinical implementation ... prevent or reverse immune system damage following critical ...
Breaking Biology News(10 mins):Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3Immune function predicts infection risk among child trauma patients 2Immune function predicts infection risk among child trauma patients 3
... lesson or two from tiny cells on how to maximize ... at Chicago have found that intra-cellular trafficking is tightly coordinated ... on a crowded road are allowed to pass quickly through ... molecular mechanism that underlies this coordination is reported by lead ...
... for over 50 years that moths can hear the ultrasonic ... are among the simplest in the insect world—they have only ... Previously, it was thought that these ears were only partially ... it would seem likely that by using high ultrasound, bats ...
... a medical case of Jekyll and Hyde, carbon monoxide ... faulty heating systems ?has proven effective in treating the ... condition that typically leads to right heart failure and ... animal study led by researchers at Beth Israel Deaconess ...
Cached Biology News:Molecular mechanism provides intra-cellular traffic signal 2Therapeutic role found for carbon monoxide 2Therapeutic role found for carbon monoxide 3
Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
... kit contains 5 ml CELLection Dynabeads (4.5 ... the human epithelial antigen EpCAM and DNase ... log enrichment of epithelial tumour cells directly ... cells clumps can be enriched from bone ...
... Cy3 Ab Labeling Kit, 1 kit. ... with CyDye fluorescent dyes. Conjugations are ... complete within 1 h. Dyes are ... to ensure consistent labelings. Category: Blotting ...
PHOTOMAN DIRECT COPY CAMERA, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: